The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liao, H.-X.
Right arrow Articles by Haynes, B. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liao, H.-X.
Right arrow Articles by Haynes, B. F.
The Journal of Immunology, 2000, 165: 148-157.
Copyright © 2000 by The American Association of Immunologists

Linkage of the CCR5{Delta}32 Mutation with a Functional Polymorphism of CD45RA1

Hua-Xin Liao2, David C. Montefiori, Dhavalkumar D. Patel, David M. Lee, William K. Scott, Margaret Pericak-Vance and Barton F. Haynes

Departments of Medicine, Immunology, and Surgery, Center for AIDS Research, Center for Human Genetics, and Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710

A 32-bp deletion in CCR5 (CCR5{Delta}32) confers to PBMC resistance to HIV-1 isolates that use CCR5 as a coreceptor. To study this mutation in T cell development, we have screened 571 human thymus tissues for the mutation. We identified 72 thymuses (12.6%) that were heterozygous and 2 (0.35%) that were homozygous for the CCR5{Delta}32 mutation. We found that thymocyte development was normal in both CCR5{Delta}32 heterozygous and homozygous thymuses. In 3% of thymuses we identified a functional polymorphism of CD45RA, in which cortical and medullary thymocytes failed to down-regulate the 200- and 220-kDa CD45RA isoforms during T cell development. Moreover, we found an association of this CD45 functional polymorphism in thymuses with the CCR5{Delta}32 mutation (p = 0.00258). In vitro HIV-1 infection assays with CCR5-using primary isolates demonstrated that thymocytes with the heterozygous CCR5{Delta}32 mutation produced less p24 than did CCR5 wild-type thymocytes. However, the functional CD45RA polymorphism did not alter the susceptibility of thymocytes to HIV-1 infection. Taken together, these data demonstrate association of the CCR5{Delta}32 mutation with a polymorphism in an as yet unknown gene that is responsible for the ability to down-regulate the expression of high m.w. CD45RA isoforms. Although the presence of the CCR5{Delta}32 mutation down-regulates HIV-1 infection of thymocytes, the functional CD45RA polymorphism does not alter the susceptibility of thymocytes to HIV-1 infection in vitro.




This article has been cited by other articles:


Home page
J. Immunol.Home page
E. Z. Tchilian, D. L. Wallace, N. Imami, H.-X. Liao, C. Burton, F. Gotch, J. Martinson, B. F. Haynes, and P. C. L. Beverley
The Exon A (C77G) Mutation Is a Common Cause of Abnormal CD45 Splicing in Humans
J. Immunol., May 15, 2001; 166(10): 6144 - 6148.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Z. Tchilian, D. L. Wallace, R. S. Wells, D. R. Flower, G. Morgan, and P. C. L. Beverley
A Deletion in the Gene Encoding the CD45 Antigen in a Patient with SCID
J. Immunol., January 15, 2001; 166(2): 1308 - 1313.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.